Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver

Leejane Lu, S. K. Demetriou, E. F. Domino

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The content of N,N-dimethyltryptamine (DMT) in the brain and liver of adult male Holtzman rats was determined after different pretreatment times with various drugs. The agents used for pretreatment were given i.p., unless otherwise specified on a mg/kg free base calculation and were as follows: chlorpromazine (0.032 to 18), haloperidol (0.1 to 3.2), thiothixene (0.1 to 3.2), octoclothepin (0.1 to 3.2), methiothepin (0.1 to 3.2), molindone (0.1 to 10.0), phenobarbital (45-90 as salt) and SKF 525-A (100 as salt). The chronic effects of chlorpromazine and phenobarbital on DMT levels were also studied in the rat. The drug dose of nonlabeled cold DMT was either 3.2 or 10.0 mg/kg as free base, while the dose of radioactive side chain-1-DMT was 3.14 mg/kg as free base. Cold DMT was assayed spectrophotofluorometrically while radioactive DMT and its acid metabolites were measured by a liquid scintillation counter. Neuroleptics varied markedly in their ability to alter DMT content. Octoclothepin was > haloperidol > methiothepin in reducing brain DMT content while chlorpromazine and molindone increased it. In contrast, chlorpromazine was > haloperidol > molindone > methiothepin in elevating DMT liver content while methiothepin and octoclothepin had biphasic effects in the liver. In general, the indoleacetic acid level was not markedly affected. Chronic phenobarbital lowered brain DMT and SKF 525-A pretreatment elevated brain and liver DMT levels.

Original languageEnglish (US)
Pages (from-to)117-133
Number of pages17
JournalArchives Internationales de Pharmacodynamie et de Therapie
Volume232
Issue number1
StatePublished - 1978
Externally publishedYes

Fingerprint

N,N-Dimethyltryptamine
Proadifen
Phenobarbital
Antipsychotic Agents
Liver
Brain
Methiothepin
Molindone
Chlorpromazine
Haloperidol
Thiothixene
Salts
Scintillation Counting
Pharmaceutical Preparations
Sprague Dawley Rats

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver. / Lu, Leejane; Demetriou, S. K.; Domino, E. F.

In: Archives Internationales de Pharmacodynamie et de Therapie, Vol. 232, No. 1, 1978, p. 117-133.

Research output: Contribution to journalArticle

@article{6c1fd39af56448eb828710a1bfc89e24,
title = "Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver",
abstract = "The content of N,N-dimethyltryptamine (DMT) in the brain and liver of adult male Holtzman rats was determined after different pretreatment times with various drugs. The agents used for pretreatment were given i.p., unless otherwise specified on a mg/kg free base calculation and were as follows: chlorpromazine (0.032 to 18), haloperidol (0.1 to 3.2), thiothixene (0.1 to 3.2), octoclothepin (0.1 to 3.2), methiothepin (0.1 to 3.2), molindone (0.1 to 10.0), phenobarbital (45-90 as salt) and SKF 525-A (100 as salt). The chronic effects of chlorpromazine and phenobarbital on DMT levels were also studied in the rat. The drug dose of nonlabeled cold DMT was either 3.2 or 10.0 mg/kg as free base, while the dose of radioactive side chain-1-DMT was 3.14 mg/kg as free base. Cold DMT was assayed spectrophotofluorometrically while radioactive DMT and its acid metabolites were measured by a liquid scintillation counter. Neuroleptics varied markedly in their ability to alter DMT content. Octoclothepin was > haloperidol > methiothepin in reducing brain DMT content while chlorpromazine and molindone increased it. In contrast, chlorpromazine was > haloperidol > molindone > methiothepin in elevating DMT liver content while methiothepin and octoclothepin had biphasic effects in the liver. In general, the indoleacetic acid level was not markedly affected. Chronic phenobarbital lowered brain DMT and SKF 525-A pretreatment elevated brain and liver DMT levels.",
author = "Leejane Lu and Demetriou, {S. K.} and Domino, {E. F.}",
year = "1978",
language = "English (US)",
volume = "232",
pages = "117--133",
journal = "Archives Internationales de Pharmacodynamie et de Therapie",
issn = "0003-9780",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver

AU - Lu, Leejane

AU - Demetriou, S. K.

AU - Domino, E. F.

PY - 1978

Y1 - 1978

N2 - The content of N,N-dimethyltryptamine (DMT) in the brain and liver of adult male Holtzman rats was determined after different pretreatment times with various drugs. The agents used for pretreatment were given i.p., unless otherwise specified on a mg/kg free base calculation and were as follows: chlorpromazine (0.032 to 18), haloperidol (0.1 to 3.2), thiothixene (0.1 to 3.2), octoclothepin (0.1 to 3.2), methiothepin (0.1 to 3.2), molindone (0.1 to 10.0), phenobarbital (45-90 as salt) and SKF 525-A (100 as salt). The chronic effects of chlorpromazine and phenobarbital on DMT levels were also studied in the rat. The drug dose of nonlabeled cold DMT was either 3.2 or 10.0 mg/kg as free base, while the dose of radioactive side chain-1-DMT was 3.14 mg/kg as free base. Cold DMT was assayed spectrophotofluorometrically while radioactive DMT and its acid metabolites were measured by a liquid scintillation counter. Neuroleptics varied markedly in their ability to alter DMT content. Octoclothepin was > haloperidol > methiothepin in reducing brain DMT content while chlorpromazine and molindone increased it. In contrast, chlorpromazine was > haloperidol > molindone > methiothepin in elevating DMT liver content while methiothepin and octoclothepin had biphasic effects in the liver. In general, the indoleacetic acid level was not markedly affected. Chronic phenobarbital lowered brain DMT and SKF 525-A pretreatment elevated brain and liver DMT levels.

AB - The content of N,N-dimethyltryptamine (DMT) in the brain and liver of adult male Holtzman rats was determined after different pretreatment times with various drugs. The agents used for pretreatment were given i.p., unless otherwise specified on a mg/kg free base calculation and were as follows: chlorpromazine (0.032 to 18), haloperidol (0.1 to 3.2), thiothixene (0.1 to 3.2), octoclothepin (0.1 to 3.2), methiothepin (0.1 to 3.2), molindone (0.1 to 10.0), phenobarbital (45-90 as salt) and SKF 525-A (100 as salt). The chronic effects of chlorpromazine and phenobarbital on DMT levels were also studied in the rat. The drug dose of nonlabeled cold DMT was either 3.2 or 10.0 mg/kg as free base, while the dose of radioactive side chain-1-DMT was 3.14 mg/kg as free base. Cold DMT was assayed spectrophotofluorometrically while radioactive DMT and its acid metabolites were measured by a liquid scintillation counter. Neuroleptics varied markedly in their ability to alter DMT content. Octoclothepin was > haloperidol > methiothepin in reducing brain DMT content while chlorpromazine and molindone increased it. In contrast, chlorpromazine was > haloperidol > molindone > methiothepin in elevating DMT liver content while methiothepin and octoclothepin had biphasic effects in the liver. In general, the indoleacetic acid level was not markedly affected. Chronic phenobarbital lowered brain DMT and SKF 525-A pretreatment elevated brain and liver DMT levels.

UR - http://www.scopus.com/inward/record.url?scp=0018095393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018095393&partnerID=8YFLogxK

M3 - Article

VL - 232

SP - 117

EP - 133

JO - Archives Internationales de Pharmacodynamie et de Therapie

JF - Archives Internationales de Pharmacodynamie et de Therapie

SN - 0003-9780

IS - 1

ER -